Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Personalizing antiplatelet therapy with clopidogrel.

Clinical pharmacology and therapeutics - 1 Oct 2012

Trenk D, Zolk O, Fromm M F, Neumann F-J, Hochholzer W

Abstract excerpt

Dual antiplatelet therapy with aspirin and clopidogrel is the accepted standard for prevention of ischemic complications after percutaneous coronary intervention and has been shown to reduce cardiovascular events in patients with acute coronary syndromes (ACSs). There is substantial interindividual variability in antiplatelet response to clopidogrel. Various clinical studies have demonstrated that patients with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blood Platelets
Share to Clopidogrel
Share to Genotype

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Phenotype

Share to Platelet Aggregation Inhibitors

Share to Precision Medicine

Share to Ticlopidine

Share to Treatment Outcome

Source

Identifiers

PMID: 22948893
DOI: 10.1038/clpt.2012.133

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Personalizing antiplatelet therapy with clopidogrel.PMID 22948893Read ↗

High on-clopidogrel platelet reactivity: genotyping can help to optimize antiplatelet treatment.Semantic proximity Read ↗

The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and PharmacometabolomicsSemantic proximity Read ↗

Influence of genetic polymorphisms on platelet function, response to antiplatelet drugs and clinical outcomes in patients with coronary artery disease.Semantic proximity Read ↗

Pharmacogenetics of Antiplatelet Therapy.Semantic proximity Read ↗

The genetic basis of platelet responsiveness to clopidogrel. A critical review of the literature.Semantic proximity Read ↗

Pharmacogenetics of antiplatelet therapy.Semantic proximity Read ↗

Platelet function and antiplatelet therapy in cardiovascular disease: implications of genetic polymorphisms.Semantic proximity Read ↗

Most Recent Evidence Behind Aggregometry and Genotyping Methods as Platelet Function Testing for Tailored Anti-Platelet Treatment Among PCI Patients.Semantic proximity Read ↗

Clopidogrel pharmacogenetics: Beyond candidate genes and genome-wide association studies.Semantic proximity Read ↗

The pharmacogenetics of antiplatelet agents: towards personalized therapy?Semantic proximity Read ↗

International Consensus Statement on Platelet Function and Genetic Testing in Percutaneous Coronary Intervention: 2024 Update.Semantic proximity Read ↗

Potential clinical utility of genetic and platelet function tests in patients on treatment with clopidogrel.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.